Tekla Life Sciences Investors

NYSE: HQL · Financial Services · Asset Management

PublicHQ Philadelphia, MACIK 0000884121Reports USD

#1 of 1,010 Financial Services companies by revenue

EA Score

——

FH —DQ —GM —SS 83

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, market scale

Methodology →

Revenue TTM

$79.8M

Rev growth YoY (TTM)

+44.5%

Net income (FY)

—

Employees

—

as of 2026-09-12

Market cap

$600.9M

as of 2026-09-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Tekla Life Sciences Investors’s financial profile?

Tekla Life Sciences Investors has no structured financials on file — private or non-XBRL filer.

Peers · Financial Services

First Business Financial Services, Inc.——American Bitcoin Corp——Unity Bancorp, Inc.——Nuveen Churchill Direct Lending Corp.——Northpointe Bancshares, Inc.——Bridgewater Bancshares, Inc.——

Key facts

CEODaniel R. Omstead

SectorFinancial Services

IndustryAsset Management

HeadquartersPhiladelphia, MA

ExchangeNYSE: HQL

Employees—

IPO date1992-05-01

Latest filings

DEF 14A2024-04-22 8-K2023-09-12 DEF 14A2023-04-11 DEF 14A2022-04-12 DEF 14A2019-04-15 DEF 14A2018-04-18 DEF 14A2017-04-18 DEF 14A2014-04-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.